TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 21,131 | 24,507 | 23,037 |
Financial expenses | 45 | 16 | 22 |
Earnings before taxes | 150 | 4,000 | 2,502 |
EBITDA | 563 | 4,331 | 2,817 |
Total assets | 23,623 | 22,095 | 10,664 |
Current assets | 12,684 | 11,007 | 9,412 |
Current liabilities | 4,070 | 3,193 | 3,248 |
Equity capital | 15,338 | 15,713 | 4,579 |
- share capital | 189 | 195 | 210 |
Employees (average) | 14 | 14 | 14 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 64.9% | 71.1% | 42.9% |
Turnover per employee | 1,509 | 1,750 | 1,646 |
Profit as a percentage of turnover | 0.7% | 16.3% | 10.9% |
Return on assets (ROA) | 0.8% | 18.2% | 23.7% |
Current ratio | 311.6% | 344.7% | 289.8% |
Return on equity (ROE) | 1.0% | 25.5% | 54.6% |
Change turnover | -2,640 | 3,062 | -2,046 |
Change turnover % | -11% | 14% | -8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.